Aster Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-384
Closed -$52.4K 1535
2024
Q4
$52.4K Sell
384
-75
-16% -$10.2K 0.02% 483
2024
Q3
$52.9K Buy
+459
New +$52.9K 0.01% 485